Intas Pharmaceuticals Ltd
Fortune 500 2023
+ 2 More
+ 2 More
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Fortune 500 India
#176(2023)
#102(2022)
#138(2021)
#176(2023)#102(2022)#138(2021)
Financial Data 2023
Revenue
19,702
(INR Cr)
Net Operating Income
19,883
(INR Cr)
Assets
19,956
(INR Cr)
Profit
2,423
(INR Cr)
Net Worth
17,227
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 19702 5.4% | 18691 11.1% | 16823 67.1% | 10068 16.2% | 8666 18.4% | 7322 11.3% | 6579 12.9% | 5826 10.0% | 5296 19.4% | 4437 23.7% | 3586 22.1% | 2938 37.7% | 2134 30.1% | 1640 27.9% | 1282 - |
| Net Operating Income (INR Cr) | 19883 8.35% | 18351 11.53% | 16454 0.00% | 9583 14.32% | 8382 18.04% | 7102 10.82% | 6408 14.22% | 5611 27.90% | 5117 22.40% | 4181 17.36% | 3563 28.73% | 2767 43.11% | 1934 21.53% | 1591 0.00% | 1156 22.11% |
| Profit (INR Cr) | 2423 -9.6% | 2679 17.0% | 2290 50.8% | 1519 24.4% | 1221 -1.1% | 1234 19.2% | 1036 -3.3% | 1071 74.5% | 614 16.6% | 526 35.2% | 389 35.0% | 288 27.7% | 226 14.5% | 197 70.1% | 116 - |
| Assets (INR Cr) | 19956 10.3% | 18098 -1.8% | 18427 40.6% | 13109 14.7% | 11428 16.5% | 9812 18.1% | 8307 57.0% | 5292 44.6% | 3659 20.8% | 3029 12.2% | 2700 5.8% | 2551 21.8% | 2095 93.0% | 1085 28.0% | 848 - |
| Net Worth (INR Cr) | 17227 17.3% | 14681 21.1% | 12121 0.0% | 9974 15.9% | 8604 16.1% | 7409 18.9% | 6231 20.0% | 5194 23.7% | 2803 25.5% | 2233 27.2% | 1755 48.4% | 1183 21.7% | 972 70.7% | 570 0.0% | 439 36.0% |
| Employee Cost (INR Cr) | 3363 14.4% | 2940 13.4% | 2593 95.3% | 1327 14.4% | 1161 21.4% | 956 18.1% | 809 23.2% | 657 -0.9% | 663 24.8% | 531 21.4% | 438 24.9% | 350 44.4% | 243 36.8% | 177 124.0% | 79 - |
| Interest Cost (INR Cr) | 126 | 111 | 267 | 177 | 29 | 115 | 36 | 18 | 26 | 40 | 60 | 95 | 52 | 33 | 23 |
| Cash & Bank Balance (INR Cr) | 3436 | 2254 | 3282 | 256 | 29 | 72 | 30 | 24 | 75 | 89 | 57 | 36 | 52 | 45 | 16 |
| Total Debt (INR Cr) | 1464 | 2359 | 5243 | 2948 | 2636 | 2250 | 1959 | 4 | 777 | 705 | 863 | 1166 | 974 | 507 | 408 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 12.3% | 14.3% | 13.6% | 15.1% | 14.1% | 16.9% | 15.7% | 18.4% | 11.6% | 11.9% | 10.9% | 9.8% | 10.6% | 12.0% | 9.1% |
| Profit As % Of Assets | 12.1% | 14.8% | 12.4% | 11.6% | 10.7% | 12.6% | 12.5% | 20.2% | 16.8% | 17.4% | 14.4% | 11.3% | 10.8% | 18.2% | 13.7% |
| Profit As % Of Networth | 14.1% | 18.3% | 18.9% | 15.2% | 14.2% | 16.7% | 16.6% | 20.6% | 21.9% | 23.6% | 22.2% | 24.4% | 23.2% | 34.6% | 26.4% |
| Interest Cost to EBITDA % | 3.4% | 2.8% | 7.2% | 8.2% | 1.6% | 6.1% | 2.3% | 1.1% | 2.9% | 5.6% | 9.2% | 18.4% | 16.1% | 12.2% | 31.2% |
| Debt to Equity Ratio | 0.08 | 0.16 | 0.43 | 0.30 | 0.31 | 0.30 | 0.31 | 0.00 | 0.28 | 0.32 | 0.49 | 0.99 | 1.00 | 0.89 | 0.93 |
| RONW | 15.2% | 20.0% | 18.9% | 16.4% | 15.2% | 18.1% | 18.1% | 22.8% | 24.6% | 26.9% | 32.1% | 25.9% | 27.7% | 35.0% | 30.4% |
| ROCE | 16.7% | 18.6% | 16.8% | 18.1% | 15.1% | 18.8% | 20.1% | 27.1% | 25.3% | 26.8% | 25.6% | 20.1% | 19.3% | 24.4% | 21.0% |